Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-13-017862
Filing Date
2013-03-19
Accepted
2013-03-19 17:12:24
Documents
1
Period of Report
2013-02-05

Document Format Files

Seq Description Document Type Size
1 rrd370294.html 4/A  
1 rrd370294.xml 4/A 7580
  Complete submission text file 0001181431-13-017862.txt   8881
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE ROCKVILLE MD 20850
Business Address
Khattar Jack A. (Reporting) CIK: 0001539937 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35518 | Film No.: 13702627